LLMs in Regulatory Affairs:
Ensuring Transparency and Trust in Regulated Industries
In recent years, the adoption of artificial intelligence (AI) and machine learning (ML) technologies has surged across various industries, promising to revolutionise decision-making processes, automate tasks, and unlock new opportunities for innovation. However, as AI systems become increasingly integrated into critical applications in regulated industries such as healthcare, finance, and legal.
Generative AI (GenAI) has brought about significant advancements in various fields. However, its adoption in regulated industries like healthcare has raised concerns about Quality & Consistency, Trust, Data Privacy, Security, Regulatory Compliance & stability, Data Bias, and lack of control output.
Let’s delve into these concerns in more detail and discuss crossing these barriers:
Quality & Consistency:
Challenge:
Ensuring the quality and consistency of LLM-generated content, such as medical reports, diagnoses, or treatment recommendations, is critical in healthcare. LLMs may produce outputs with varying levels of accuracy, completeness, and relevance, leading to potential errors or inconsistencies.
Solution:
Rigorous validation and evaluation processes, including prompt engineering, creating application wrappers, domain-specific quality assurance checks, human review, and benchmarking against established standards, are essential to assess the quality and consistency of LLM-generated outputs.
Trust & Explainability:
Challenge:
Building trust among healthcare professionals, patients, and regulatory authorities in LLM-driven healthcare applications requires transparency and explainability. The opaque nature of LLMs makes it challenging to understand how they arrive at specific decisions or recommendations, hindering trust and acceptance.
Solution:
Using eXplainable AI (XAI):
Explainable AI (XAI) refers to the set of techniques, methodologies, and frameworks designed to make AI systems more transparent, interpretable, and understandable to humans. The fundamental goal of XAI is to enable stakeholders, including regulators, policymakers, domain experts, and end-users, to comprehend the rationale behind AI-driven decisions and predictions.
XAI techniques, such as LIME or SHAP, to provide interpretable explanations for LLM predictions can enhance trust and facilitate understanding of the model’s decision-making process. Additionally, promoting transparency through documentation, validation studies, and stakeholder engagement can foster trust in LLM-driven healthcare solutions.
Moreover, design AI systems with a user-centric approach, prioritizing user needs, preferences, and comprehension. Provide intuitive explanations and visualisations of AI predictions to enhance user understanding and trust.
Data Privacy & Security:
Challenge:
Safeguarding patient privacy and protecting sensitive healthcare data from unauthorized access or misuse is paramount in LLM applications. LLMs trained on healthcare data may inadvertently reveal personally identifiable information (PII) or protected health information (PHI), leading to privacy breaches.
Solution:
Enterprise-grade APIs (e.g. Azur APIs, AWS) address concerns around privacy, and security & are easy to integrate. Implementing robust data anonymization, encryption, access controls, and compliance with data protection regulations such as HIPAA or GDPR are essential to ensure data privacy and security in LLM-driven healthcare applications. Secure data handling practices, including secure data storage, transmission, and processing, should be followed to mitigate privacy risks.
Teams should undertake a comprehensive Threat Modelling exercise to analyse an application by taking the perspective of an attacker to identify and quantify security risks and determine countermeasures and mitigations. In this regard, following OWASP Top 10 for LLM Applications is a helpful resource that teams can use to identify other possible LLM vulnerabilities, such as data poisoning, sensitive information disclosure, supply chain vulnerabilities, etc
In the interest of brevity, in brief, let me explain OWASP Top 10 for LLM Applications:
LLM01 Prompt Injection: Attackers can manipulate LLMs through crafted inputs, causing them to execute the attacker’s intentions.
LLM02 Insecure Output Handling: Insecure Output Handling is a vulnerability that arises when a downstream component blindly accepts large language model (LLM) output without proper scrutiny. This can lead to XSS and CSRF in web browsers as well as SSRF, privilege escalation, or remote code execution on backend systems.
LLM03 Training Data Poisoning: Training Data Poisoning refers to manipulating the data or fine-tuning process to introduce vulnerabilities, backdoors or biases that could compromise the model’s security, effectiveness or ethical behaviour. This risks performance degradation, downstream software exploitation and reputational damage.
LLM04 Model Denial of Service: Occurs when an attacker interacts with a Large Language Model (LLM) in a way that consumes an exceptionally high amount of resources. This can result in a decline in the quality of service for them and other users, as well as potentially incurring high resource costs.
LLM05 Supply Chain Vulnerabilities: Supply chain vulnerabilities in LLMs can compromise training data, ML models, and deployment platforms, causing biased results, security breaches, or total system failures. Such vulnerabilities can stem from outdated software, susceptible pre-trained models, poisoned training data, and insecure plugin designs.
LLM06 Sensitive Information Disclosure: LLM applications can inadvertently disclose sensitive information, proprietary algorithms, or confidential data, leading to unauthorised access, intellectual property theft, and privacy breaches. To mitigate these risks, LLM applications should employ data sanitisation, implement appropriate usage policies, and restrict the types of data returned by the LLM
LLM07 Insecure Plugin Design: Plugins can be prone to malicious requests leading to harmful consequences like data exfiltration, remote code execution, and privilege escalation due to insufficient access controls and improper input validation. Developers must follow robust security measures to prevent exploitation, like strict parameterized inputs and secure access control guidelines.
LLM08 Excessive Agency: Excessive Agency in LLM-based systems is a vulnerability caused by over-functionality, excessive permissions, or too much autonomy. To prevent this, developers need to limit plugin functionality, permissions, and autonomy to what’s necessary, track user authorization, require human approval for all actions, and implement authorization in downstream systems.
LLM09 Over-reliance: Over-reliance on LLMs can lead to serious consequences such as misinformation, legal issues, and security vulnerabilities. It occurs when an LLM is trusted to make critical decisions or generate content without adequate oversight or validation.
LLM10 Model Theft: LLM model theft involves unauthorised access to and exfiltration of LLM models, risking economic loss, reputation damage, and unauthorised access to sensitive data. Robust security measures are essential to protect these models.
Regulatory Compliance & Stability:
Challenge:
Meeting regulatory requirements and maintaining model stability over time are significant challenges in deploying LLMs in healthcare. Regulatory compliance standards, such as ISO 13485, ISO 14971, IEC 62304, HIPAA or FDA guidelines, impose stringent requirements on data handling, model validation, and documentation, which must be adhered to.
Solution:
Conducting thorough regulatory assessments, ensuring compliance with relevant standards, and maintaining comprehensive documentation of LLM development and deployment processes are essential to meet regulatory requirements. Continuous monitoring, validation, and updating of LLMs to ensure stability and reliability are also critical for long-term compliance.
Data Bias:
Challenge:
Addressing biases in healthcare data, such as demographic disparities or under-representation of certain populations, is crucial to prevent biased outcomes or inequitable healthcare delivery in LLM applications. Biases in training data can propagate through LLMs and result in unfair or inaccurate predictions.
Solution:
Establish governance frameworks and ethical guidelines for AI development and deployment, emphasizing transparency, accountability, and fairness. e.g. EU Requirements of Trustworthy AI and Australia’s AI Ethics Principles. These guidelines were helpful in guiding our CX design in ethical grey areas or danger zones.
Conducting bias audits, fairness assessments, and diversity analyses on training data to identify and mitigate biases are essential steps in mitigating bias in LLM applications. Employing fairness-aware training techniques, diverse dataset curation, and demographic parity measures can help promote fairness and equity in LLM-driven healthcare solutions.
Lack of Control on Output:
Challenge:
Ensuring control over LLM-generated outputs, particularly in critical healthcare settings, is challenging due to the autonomous nature of LLMs. Unpredictable or undesirable outputs generated by LLMs may pose risks to patient safety, diagnosis accuracy, or treatment efficacy.
Solution:
Implementing mechanisms for human oversight, intervention, or approval of LLM outputs, such as human-in-the-loop systems or decision support tools, can provide additional control and accountability in LLM-driven healthcare applications. Establishing clear protocols for handling unexpected or ambiguous outputs and incorporating clinician feedback into model refinement processes can enhance control over LLM outputs.
